« » veeva.com 9 Key Considerations When Evaluating a Pharmacovigilance Solution 1 Pharmacovigilance organizations are facing growing adverse event volumes, increasing disease complexity, and challenging global regulations. There is also rising pressure for safety teams to demonstrate greater value with tighter budgets. Leveraging new and innovative technologies can provide cost and process efficiencies, and make it easier for pharmacovigilance teams to perform advanced tasks. Many companies are adopting modern applications or upgrading their internal systems to reduce overhead and get more from their investments. As pharmacovigilance teams evaluate new safety solutions, they need to consider the following: 1. NUMBER OF SOLUTIONS TO MEET YOUR END-TO-END

Join for free to read